Redox-programmed theranostic system with instant Response: Light-Triggered methylene blue activation driving self-amplified PDT through glutathione depletion and synergistic chemotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. A carbonic anhydrase-targeted NIR-II fluorescent cisplatin theranostic nanoparticle for combined therapy of pancreatic tumors10.1016/j.biomaterials.2023.122454 ↗
2. Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies
3. Traceable nanoparticles with dual targeting and ROS response for RNAi-Based immunochemotherapy of intracranial glioblastoma treatment10.1002/adma.201705054 ↗
4. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment10.1038/s41467-022-35033-7 ↗
5. Molecularly imprinted polymer-based smart prodrug delivery system for specific targeting, prolonged retention, and tumor microenvironment-triggered release10.1002/anie.202012956 ↗
6. Advances in redox-responsive drug delivery systems of tumor microenvironment
7. Responsive fluorescent probes for cellular microenvironment and redox small biomolecules10.1016/j.trac.2023.117377 ↗
8. Smart unimolecular micelle-based polyprodrug with dual-redox stimuli response for tumor microenvironment: enhanced in vivo delivery efficiency and tumor penetration10.1021/acsami.9b13214 ↗
9. Research progress of disulfide bond based tumor microenvironment targeted drug delivery system10.2147/IJN.S471734 ↗
10. Disulfide bond-based SN38 prodrug nanoassemblies with high drug loading and reduction-triggered drug release for pancreatic cancer therapy10.2147/IJN.S404848 ↗
11. Tumor microenvironment Cascade activated biodegradable nano-enzymes for glutathione-depletion and ultrasound-enhanced chemodynamic therapy10.1002/smll.202405457 ↗
12. A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion10.1016/j.biomaterials.2018.04.016 ↗
13. Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy10.1021/acsnano.8b06400 ↗
14. Glutathione-responsive nanoparticles of camptothecin prodrug for cancer therapy10.1002/advs.202205246 ↗
15. Polyprodrug with glutathione depletion and Cascade drug activation for multi-drug resistance reversal10.1016/j.biomaterials.2020.120649 ↗
16. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis10.1016/j.jconrel.2018.06.027 ↗
17. Supramolecular prodrug-like nanotheranostics with dynamic and activatable nature for synergistic photothermal immunotherapy of metastatic cancer10.1016/j.jconrel.2024.01.052 ↗
18. Tumor microenvironment-responsive nanocarrier based on VOx nanozyme amplify oxidative stress for tumor therapy10.1002/adfm.202212740 ↗
19. Nanodrug delivery systems for targeting the endogenous tumor microenvironment and simultaneously overcoming multidrug resistance properties10.1016/j.jconrel.2017.02.020 ↗
20. Precise subcellular organelle targeting for boosting endogenous-stimuli-mediated tumor therapy10.1002/adma.202101572 ↗
21. Endogenous stimuli-activatable nanomedicine for immune theranostics for cancer10.1002/adfm.202100386 ↗
22. Self-boosting programmable release of multiple therapeutic agents by activatable heterodimeric prodrug-enzyme assembly for antitumor therapy10.1002/advs.202409960 ↗
23. A novel ROS-Activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone10.1016/j.biomaterials.2022.121954 ↗
24. External stimuli-responsive gasotransmitter prodrugs: chemistry and spatiotemporal release10.1016/j.jconrel.2022.09.026 ↗
25. Biomimetic nanosystems harnessing NIR-II photothermal effect and hypoxia-responsive prodrug for self-amplifying and synergistic tumor treatment10.1016/j.nantod.2024.102395 ↗
26. Endogenous/Exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity10.1016/j.nantod.2022.101727 ↗
27. Stimuli-responsive polyprodrug for cancer therapy
28. Stimuli-responsive ferroptosis for cancer therapy10.1039/D3CS00001J ↗
29. A polyplatin with hands-holding Near-Infrared-II fluorophores and prodrugs at a precise ratio for tracking drug fate with realtime readout and treatment feedback10.1002/adma.202402452 ↗
30. A smart Cascade theranostic prodrug system activated by hydrogen peroxide for podophyllotoxin delivery10.1039/D4TB02182G ↗
31. Cancer cell-specific fluorescent prodrug delivery platforms10.1002/advs.202207768 ↗
32. Cooperative bond scission by HRP/H2O2 for targeted prodrug activation10.1016/j.cclet.2024.109663 ↗
33. Recent advances in radiation therapy and photodynamic therapy10.1063/5.0060424 ↗
34. Atomic-level nanorings (A-NRs) therapeutic agent for photoacoustic imaging and photothermal/photodynamic therapy of cancer10.1021/jacs.9b11553 ↗
35. A general strategy towards activatable nanophotosensitizer for phototoxicity-free photodynamic therapy10.7150/thno.100597 ↗
36. Glutathione-driven disassembly of planar organic phototherapeutic agents to enhance photodynamic-photothermal therapy performance for nasopharyngeal carcinoma10.1002/smll.202409196 ↗
37. AIE based GSH activatable photosensitizer for imaging-guided photodynamic therapy10.1039/D0CC02045A ↗
38. Activatable photosensitizers: from fundamental principles to advanced designs
39. Self-assembled nano-photosensitizer for targeted, activatable, and biosafe cancer phototheranostics10.1016/j.biomaterials.2022.121916 ↗
40. Targeting tumor microenvironment with RGD-Functionalized nanoparticles for precision cancer therapy10.1016/j.canlet.2025.217536 ↗
41. Single-component dual-functional autoboost strategy by dual photodynamic and Cyclooxygenase-2 inhibition for lung cancer and spinal metastasis10.1002/advs.202303981 ↗
42. A naphthalimide-based fluorescent probe for quantitative sensing of UV light. Dyes
43. Sanger's reagent as a new general phototrigger for organelle imaging10.1016/j.snb.2023.134742 ↗
44. Recent progress of photocage molecules and materials10.6023/A20080361 ↗
45. Light-triggered release of lenalidomide with fluorescent indication for inhibition of COX-2 enzyme activity in cancer cells10.1039/D5CC00695C ↗